Company Info
Year Established2022
Contacts
Kurt HarringtonFounder & CEO
Ken Lipson, Ph.D
CSO
Company Description
Ventoux Biosciences is a privately held pharmaceutical company focused on acquiring, in-licensing, developing, and commercializing proprietary products for Dupuytrenメs Disease, Ledderhose Disease, and related fibroproliferative, inflammatory conditions with significant unmet medical need.